Company Overview of CG Therapeutics, Inc.
CG Therapeutics, Inc., a biotechnology company, develops human chorionic gonadotropin (hCG)-targeted cancer immunotherapeutic products. Its products include CG201, an anti-hCG vaccine, which targets hCG-producing tumors by stimulating patients’ immune systems to produce antibodies that eliminate hCG; and anti-hCG monoclonal antibodies, which are developed for therapeutic applications for treating cancer in combination with CG201. The company serves government agencies, universities, and corporations. CG Therapeutics was founded in 2005 and is based in Seattle, Washington.
2815 Eastlake Avenue East
Seattle, WA 98102
Founded in 2005
Key Executives for CG Therapeutics, Inc.
Similar Private Companies By Industry
|Bayer HealthCare Pharmaceuticals Inc.||United States|
|Vitae Pharmaceuticals, Inc.||United States|
|Zymetis, Inc.||United States|
|American Sterilizer Company||United States|
|Sigmapharm Laboratories, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York, NY | Robert W. BairdPosted: Apr 21
- Efland, NC | Orange County SchoolsPosted: May 19
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- Rockville, MD | Lab Support, A Division of On AssignmentPosted: May 02
Sponsored Financial Commentaries
To contact CG Therapeutics, Inc., please visit www.cgtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.